SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $999,860 | +2.4% | 1,000,000 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $976,574 | +0.7% | 1,000,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $970,000 | -0.1% | 1,000,000 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $971,000 | -1.5% | 1,000,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $986,000 | – | 1,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 71,162 | $69,799,000 | 4.72% |
ZAZOVE ASSOCIATES LLC | 27,692,000 | $27,021,000 | 2.38% |
ADVENT CAPITAL MANAGEMENT /DE/ | 61,727,000 | $60,252,000 | 1.17% |
SHENKMAN CAPITAL MANAGEMENT INC | 7,637,000 | $7,524,000 | 0.85% |
NN Investment Partners Holdings N.V. | 38,700,000 | $37,743,000 | 0.30% |
CAMDEN ASSET MANAGEMENT L P /CA | 5,825,000 | $5,684,000 | 0.18% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 4,479,000 | $4,384,000 | 0.16% |
Lombard Odier Asset Management (Europe) Ltd | 2,005,000 | $1,905,000 | 0.16% |
PRUDENTIAL PLC | 41,809,000 | $40,973,000 | 0.12% |
Calamos Advisors LLC | 22,303,000 | $21,829,000 | 0.12% |